JFG
EW icon

Jefferies Financial Group’s Edwards Lifesciences EW Stock Holding History

Jefferies Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,800
Closed -$874K – 1730
2024
Q4 		$874K Buy
+11,800
New +$826K 0.01% 927

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Jefferies Financial Group's EW Position: Q2 2026 in Review

Jefferies Financial Group reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $396K and leaving 39,620 shares worth $3.58M. The position accounts for 0.02% of the portfolio, ranked #487.

Jefferies Financial Group first reported a position in EW in Q1 2023 and has held it in 13 quarters since. The position peaked at $13.6M in Q4 2023. 1,337 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Jefferies Financial Group held 39,620 shares of Edwards Lifesciences worth $3.58M as of Q2 2026.
  • Jefferies Financial Group sold 4,731 Edwards Lifesciences shares in Q2 2026, an estimated $396K.
  • Edwards Lifesciences made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #487 holding.
  • Jefferies Financial Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
  • Jefferies Financial Group's Edwards Lifesciences position peaked at $13.6M in Q4 2023.
  • 1,337 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.